Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

cord blood-derived CMV/AdV/EBV/BKV-specific cytotoxic T lymphocytes

A population of allogeneic expanded cord blood (CB)-derived cytotoxic T lymphocytes (CTLs) that are specifically reactive to cytomegalovirus (CMV), Epstein-Barr virus (EBV), adenovirus (AdV), and human polyomavirus type I (BKV), with potential antiviral activity. Infusion of the CB-derived CMV/AdV /EBV/BKV-specific CTLs into CB hematopoietic stem cell transplant (HSCT) recipients may provide virus-specific cellular immunity, thereby preventing the infection or reactivation of certain viral-associated diseases.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:allogeneic cord blood-derived CMV/AdV/EBV/BKV-specific CTLs
cord blood-derived CMV/AdV/EBV/BKV-specific T cells
UCB-derived CMV/AdV/EBV/BKV-specific T cells
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search